ライフサイエンスコーパス: pseudophakic

1 lines of VA loss: 4 were phakic, and 2 were pseudophakic.

2 65.2%) were phakic, and 15 of 15 (100%) were pseudophakic.

3 78.9%) were phakic and 22 of 24 (91.7%) were pseudophakic.

4 rates when operated eyes were phakic versus pseudophakic.

5 ant glaucoma, 5 eyes were phakic and 23 were pseudophakic.

6 al (84.1% vs 74.4%; P = 0.16), phakic versus pseudophakic (79.1% vs 78.0%; P = 0.88), and macula-on v

7 of follow-up, the mean axial lengths of the pseudophakic and aphakic eyes were 2.0 +/- 0.2 mm and 2.

8 P acuity revealed amblyopic deficits in both pseudophakic and aphakic eyes.

9 However, in pseudophakic and aphakic patients, PPV seems to be less

10 In pseudophakic and uveitic macular edema, steroid implants

11 Combining phakic, pseudophakic, and aphakic groups, those treated with scl

12 Report of three patients with pseudophakic angle-closure from a Soemmering ring.

13 ee mechanisms of the Soemmering ring induced pseudophakic angle-closure in three patients were demons

14 nd postoperative BCVA at 6 months or more in pseudophakic/aphakic eyes.

15 ; P = 0.03) between the PPV and SB groups in pseudophakic/aphakic eyes.

16 In the pseudophakic/aphakic group, there were no significant di

17 Analysis was divided into phakic and pseudophakic/aphakic patients.

18 Two of the 165 DMEK cases were performed for pseudophakic bullous keratopathy (2 cases, 1 in each coh

19 ndothelium compared with normal controls and pseudophakic bullous keratopathy (iatrogenic CE cell los

20 re (n = 8), DSAEK graft failure (n = 3), and pseudophakic bullous keratopathy (n = 2).

21 ation for surgery (n = 127; 90%) followed by pseudophakic bullous keratopathy (n = 4; 4%) and regraft

22 visual outcomes than penetrating grafts for pseudophakic bullous keratopathy (P <0.001).

23 ent DSAEK for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy (PBK) at a single insti

24 FED and pseudophakic bullous keratopathy (PBK) corneal buttons w

25 from age-matched normal autopsy corneas and pseudophakic bullous keratopathy (PBK) corneas.

26 Fuchs endothelial dystrophy and 9 eyes with pseudophakic bullous keratopathy (PBK) that underwent DS

27 nus (KC), Fuchs endothelial dystrophy (FED), pseudophakic bullous keratopathy (PBK), infection and ot

28 ents with Fuchs endothelial dystrophy (FED), pseudophakic bullous keratopathy (PBK), or keratoconus w

29 s correlation was strongest in patients with pseudophakic bullous keratopathy (r = -0.62 [P = .01]).

30 tudies were performed on eight cases each of pseudophakic bullous keratopathy and healthy corneas.

31 nt DSAEK with Fuchs endothelial dystrophy or pseudophakic bullous keratopathy at a single tertiary ce

32 ed PK, whose primary surgical indication was pseudophakic bullous keratopathy at a single tertiary ce

33 Oxidative DNA damage was not detected in pseudophakic bullous keratopathy corneas, whereas it col

34 n = 2074) for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy from January 2006 throu

35 surgery for Fuchs' endothelial dystrophy and pseudophakic bullous keratopathy in patients without oth

36 DMEK surgery in the treatment of pseudophakic bullous keratopathy in the presence of sf-I

37 Pseudophakic bullous keratopathy manifests an abnormal c

38 atients with Fuchs endothelial dystrophy and pseudophakic bullous keratopathy undergoing DSAEK surger

39 EK failure in pseudophakic bullous keratopathy was associated with cen

40 toplasties performed for Fuchs' dystrophy or pseudophakic bullous keratopathy was poorer than surviva

41 For both Fuchs endothelial dystrophy and pseudophakic bullous keratopathy, EK achieved better ave

42 In eyes with pseudophakic bullous keratopathy, the EndoGlide group ha

43 complications associated with them, such as pseudophakic bullous keratopathy, uveitis-glaucoma-hyphe

44 ing DSAEK for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy.

45 sulted in better graft survival in eyes with pseudophakic bullous keratopathy.

46 are being performed for Fuchs' dystrophy and pseudophakic bullous keratopathy.

47 rder to treat secondary corneal edema due to pseudophakic bullous keratopathy.

48 s relationship is strongest in patients with pseudophakic bullous keratopathy.

49 the Middle East, Africa, and South America), pseudophakic bullous keratopathy/aphakic bullous keratop

50 es of 31 patients who had Fuchs dystrophy or pseudophakic bullus keratopathy (PBK) and underwent DSAE

51 The 50% glucose reached the vitreous in pseudophakic but not phakic individuals.

52 Of 661 pseudophakic cadaver eyes obtained, 13 had 3-piece hydro

53 arithm of the minimal angle of resolution in pseudophakic children at last follow-up (P < .0001).

54 e centers for Fuchs' endothelial disease and pseudophakic corneal edema and for high-volume surgeons

55 Performing earlier DSEK for pseudophakic corneal edema appears to be associated with

56 keratoconus, Fuchs' endothelial disease, or pseudophakic corneal edema in a 7-year period from 1999

57 ptimal time to perform DSEK in patients with pseudophakic corneal edema.

58 Pseudophakic cystoid macular edema (PCME) is a common ca

59 ed phacoemulsification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospe

60 Pseudophakic cystoid macular edema is an important cause

61 Pseudophakic cystoid macular edema is common after phaco

62 TA) versus laser; (2) a subgroup analysis of pseudophakic DME eyes shows equivalent visual results wi

63 IOL implantation, optical correction of the pseudophakic eye to a near point, and 70% occlusion of t

64 ely and predict the refractive change of the pseudophakic eye to maturity.

65 Only 2 of these patients had a pseudophakic eye.

66 relative intensity values between phakic and pseudophakic eyes (0.3522 vs 0.3577, P = .48) and betwee

67 er DSEK or PK compared with otherwise normal pseudophakic eyes (P < 0.001) but did not differ between

68 = 8,), and not with age of otherwise normal pseudophakic eyes (r = 0.32, P = 0.18, n = 29).

69 The 50% width was higher in pseudophakic eyes after DSEK or PK compared with otherwi

70 dth, small-angle domain) were measured in 40 pseudophakic eyes after keratoplasty (Descemet stripping

71 Aphakic and pseudophakic eyes and eyes with best corrected visual ac

72 ive error per year and visual acuity for the pseudophakic eyes at last follow-up visit.

73 t daily 70% occlusion, grating acuity in the pseudophakic eyes eventually matured to normal adult lev

74 ies study, in which 20 trabeculectomised and pseudophakic eyes from 15 patients, with otherwise well

75 The majority of pseudophakic eyes had significant anisometropia at age 5

76 tamponade was achieved in phakic as well as pseudophakic eyes irrespective of AL of the eye.

77 Retinal image quality in pseudophakic eyes is limited by the wavefront aberration

78 Angle-closure in pseudophakic eyes is uncommon.

79 Twenty two pseudophakic eyes of 22 consecutive patients were includ

80 Cologne DMEK database who underwent DMEK in pseudophakic eyes or DMEK in combination with cataract s

81 ls of ketorolac were significantly higher in pseudophakic eyes than in phakic eyes.

82 25G HS-PPV (348 eyes), and group B included pseudophakic eyes that underwent 25G HS-PPV alone (217 e

83 t the optical correction of both aphakic and pseudophakic eyes to a near point (3-5 D).

84 used to adjust the optical correction of the pseudophakic eyes to a near point, and opaque lenses wer

85 Other studies have shown a tendency for pseudophakic eyes to progress to the wet form of age-rel

86 on of the two treatment groups revealed that pseudophakic eyes treated with multifocal IOLs had signi

87 pril 2010 and August 2012 were reviewed; 292 pseudophakic eyes underwent DMEK (group 1) and 200 eyes

88 traocular lens implantation; 20 preoperative pseudophakic eyes underwent PPV and ILM peeling only.

89 rst-line methods; the second-line therapy in pseudophakic eyes was laser hyaloidotomy, followed by vi

90 en the mean axial lengths of the aphakic and pseudophakic eyes was not significant (P > 0.10).

91 Longitudinal axial elongation of the pseudophakic eyes was then compared to that of the fello

92 When only pseudophakic eyes were analyzed, mean (SD) PGE2 levels w

93 Aphakic and pseudophakic eyes were excluded as well as eyes with bes

94 Pseudophakic eyes were more likely to lose 15 or more le

95 At 5 weeks of age, aphakic and pseudophakic eyes were significantly shorter than their

96 Phakic and pseudophakic eyes were treated with monthly intravitreal

97 ieved in 4 eyes with medical treatment, in 7 pseudophakic eyes with laser hyaloidotomy, in 4 eyes wit

98 For the study population, 240 pseudophakic eyes with PCO and a capsulotomy indication

99 The depth and width of the ACA in pseudophakic eyes with PCO increased significantly after

100 Anterior chamber depth and angle width in pseudophakic eyes with posterior capsule opacification w

101 For the reference population, 99 pseudophakic eyes without PCO were selected.

102 and 12 months after surgery 31 patients (39 pseudophakic eyes) underwent a complete ophthalmological

103 2.4% for retinal detachment, and, excluding pseudophakic eyes, 64.6% underwent cataract surgery with

104 nge in 3 groups: (1) eyes with cataract, (2) pseudophakic eyes, and (3) eyes in which cataract surger

105 All 7 were in pseudophakic eyes, and 4 of the 5 below this limit were

106 c eyes, laser hyaloidotomy was beneficial in pseudophakic eyes, and vitrectomy and TSCPC were benefic

107 ts with the CFH or ARMS2 risk genotypes, and pseudophakic eyes.

108 seen in mean change in VA for phakic versus pseudophakic eyes.

109 of Soemmering ring related angle-closure in pseudophakic eyes.

110 Fuchs' dystrophy and in 30 otherwise normal pseudophakic eyes.

111 ling and neural factors will limit vision in pseudophakic eyes.

112 Fifty-nine eyes were phakic and 58 pseudophakic eyes.

113 sitive to improved reading accessibility for pseudophakic eyes.

114 in both BRVO and CRVO and in both phakic and pseudophakic eyes.

115 ve inclusion criteria, as well as phakic and pseudophakic eyes.

116 compared with 25G HS-PPV alone performed in pseudophakic eyes.

117 l series of eyes, both trabeculectomised and pseudophakic, following the laser application for the ma

118 MAR 0.21 vs 0.27; P >0.05) and phakic versus pseudophakic groups (logMAR 0.23 vs 0.28; P >0.05).

119 ithin the first 12 months of follow-up in 38 pseudophakic infants (life-table estimate, 66.7%) and 42

120 Pseudophakic macular edema occurs commonly after phacoem

121 betic macular edema, retinal vein occlusion, pseudophakic macular edema, and uveitis.

122 A 75-year-old pseudophakic man with open-angle glaucoma and diabetic r

123 ient with keratoconus, as well as to correct pseudophakic myopia.

124 sk condition, principally Fuchs dystrophy or pseudophakic or aphakic corneal edema (PACE).

125 k condition, principally Fuchs' dystrophy or pseudophakic or aphakic corneal edema, were enrolled by

126 RD repair were estimated for both phakic and pseudophakic or aphakic patients and then were compared.

127 12% less expensive than SB for RRD repair in pseudophakic or aphakic patients.

128 In patients who were pseudophakic or were scheduled for cataract extraction,

129 groups of 9 normal subjects (17 eyes) and 17 pseudophakic patients (17 eyes) implanted with monofocal

130 tiColor imaging that occurs predominantly in pseudophakic patients and may be mistaken for true chori

131 Older pseudophakic patients have generally the same contrast s

132 Twenty pseudophakic patients who underwent ultrasound biomicros

133 Nondiabetic pseudophakic patients with definite POAG were recruited;

134 to correct residual amounts of ametropia in pseudophakic patients with monofocal intraocular lenses;

135 Early postoperative pseudophakic patients with myopic shift and narrow angle

136 ingle institution, 43 eyes of 43 consecutive pseudophakic patients with symptomatic posterior capsule

137 For pseudophakic patients, first-line treatment with triamci

138 In pseudophakic patients, the failure rate of the initial p

139 fter cataract surgery was similar to that in pseudophakic patients.

140 occur commonly in younger, nonhyperopic, and pseudophakic patients.

141 eratectomy are safe and effective results in pseudophakic patients.

142 atment for retinal detachment, especially in pseudophakic patients.

143 Phakic and pseudophakic piggyback intraocular lenses are also being

144 Astigmatism and pseudophakic presbyopia continue as the primary indicati

145 der than 70 years are more likely to develop pseudophakic PVD.

146 arman) = -0.27, p < 0.01), but more so among pseudophakic (r(Spearman) = -0.41, p < 0.01) than aphaki

147 For all eyes (both with and without PCR), pseudophakic RD occurred earlier in cases performed by a

148 Pseudophakic RD occurs earlier after cataract surgery co

149 progressed to RD surgery, the median time to pseudophakic RD surgery was 44 days for eyes with PCR, a

150 Pseudophakic RD surgery was performed on 131 eyes of 129

151 Surgeon grade is a risk factor for pseudophakic RD.

152 ye has been successfully expanded to address pseudophakic refractive error in normal eyes and eyes th

153 rent literature further defines the risk for pseudophakic retinal detachment associated with younger

154 dentifying factors that increase the risk of pseudophakic retinal detachment can aid in management.

155 e of cataract surgeries performed each year, pseudophakic retinal detachment contributes significantl

156 ontinue to be associated with higher risk of pseudophakic retinal detachment.

157 attachment rate in the management of primary pseudophakic RRD due to IRBs.

158 the loss of accommodation resulting from the pseudophakic state.

159 r studies, the significance of phakic versus pseudophakic status was not confirmed.

160 Pseudophakic study eyes demonstrated increased IOP when

161 Mean IOP for pseudophakic study eyes increased from 14.5+/-3.2 mmHg a

162 orse in those with known, treated OAG and in pseudophakic subjects.

163 refraction from medical records was used for pseudophakic subjects.

164 For pseudophakics, the ICER value for comparison triamcinolo

165 For pseudophakic uncomplicated retinal detachments, the surg

166 eyes with ghost maculopathy were found to be pseudophakic with a posterior chamber intraocular lens.

167 r 2013 in UK for treatment of eyes which are pseudophakic with DMO that is unresponsive to other avai

168 n phakic eyes was 94.9% compared to 93.1% in pseudophakic, with no statistically significant differen